Pulmonary Fibrosis: all 685 studies
Page 5 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.
- Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)Status unknownNCT04416100
- LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTIONStatus unknownNCT04409275
- Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19Status unknownNCT04338802Phase 2
- Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 InfectionStatus unknownNCT04326036Early Phase 1
- Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated CoughCompletedNCT04318704Phase 2
- Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant OutcomesCompletedNCT04316780
- Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary FibrosisCompletedNCT04312594Phase 2
- Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) TrialCompletedNCT04300920Phase 3
- Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng HuayuCompletedNCT04279197Phase 2
- A Study of the Efficacy and Safety of Rituximab in Participants With Systemic SclerosisCompletedNCT04274257Phase 2/3
- A Study of Patients With Chronic DiseaseTerminatedNCT04263727
- Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPDCompletedNCT04257630
- RENOVATE Fibrosis:HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary FibrosisTerminatedNCT04253405Not applicable
- Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPFWithdrawnNCT04244825Phase 2
- Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult SubjectsCompletedNCT04233814Phase 1
- Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT04197791Not applicable
- Immunopathologic Profiles and Blood Biomarkers in Patients With IPFCompletedNCT04187079
- Cardiovascular Fibrosis in Idiopathic Pulmonary FibrosisCompletedNCT04177251
- Oxygen Savings With Administered Oxygen and High Flow Ambient Air At RestCompletedNCT04170062Not applicable
- Quality of Life in IPF - Patient and Physician PerceptionsCompletedNCT04148157
- Enhancing Physical Activity in Patients With Interstitial Lung DiseaseCompletedNCT04138173Not applicable
- Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease ProgressionActive, not recruitingNCT04136223
- Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung DiseasesTerminatedNCT04119115
- A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327CompletedNCT04069143Phase 1
- Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis PatientsCompletedNCT04031690
- Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in SwedenStatus unknownNCT04019080
- Idiopathic Pulmonary Fibrosis and Serum BankCompletedNCT04016168
- Research of Burden of Interstititial Lung Diseases in TurkeyStatus unknownNCT03995654
- Palliative Care and Quality of Life in Idiopathic Pulmonary FibrosisCompletedNCT03981406Not applicable
- A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy ParticipantsCompletedNCT03981094Phase 1
- Yoga in Patients With Fibrosing Interstitial Lung DiseasesCompletedNCT03979703Not applicable
- Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot StudyCompletedNCT03979430Not applicable
- A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary FibrosisTerminatedNCT03949530Phase 1
- ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis EvolutionCompletedNCT03944928
- Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD ManagementTerminatedNCT03939065Not applicable
- Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)CompletedNCT03918161Not applicable
- Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)CompletedNCT03901196
- Impulse Oscillometry for Prognostication in Idiopathic Pulmonary FibrosisCompletedNCT03898284
- Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary FibrosisCompletedNCT03890250Not applicable
- Glycocalyx Biomarkers in ARDS for Clinical Prognosis and Pulmonary FibrosisStatus unknownNCT03854565
- Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective StudyCompletedNCT03836417
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy SubjectsCompletedNCT03830125Phase 1
- Impact of Air Pollution on Chronic Respiratory DiseasesStatus unknownNCT03813810
- Nutritional Assessment in Idiopathic Pulmonary FibrosisCompletedNCT03770845
- Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and EfficacyCompletedNCT03761082
- PFOX: Pulmonary Fibrosis Ambulatory Oxygen TrialCompletedNCT03737409Not applicable
- PROOF-Registry New and Extended Belgium -LuxembourgCompletedNCT03732859
- A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisCompletedNCT03727451Phase 2
- Inhaled NAC in Treatment of IPFWithdrawnNCT03720483Phase 1/2
- Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and MetabolomicsCompletedNCT03711435
- Exercise Hemodynamics in Patients With Pulmonary FibrosisStatus unknownNCT03706820
- Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving PirfenidoneStatus unknownNCT03692481Not applicable
- It's Not JUST Idiopathic Pulmonary Fibrosis StudyStatus unknownNCT03670576
- Idiopathic Pulmonary Fibrosis Registry China StudyStatus unknownNCT03666234
- To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy VolunteersCompletedNCT03650075Phase 1
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy AdultsCompletedNCT03619616Phase 1
- A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)WithdrawnNCT03591926Phase 2
- Respiratory Muscle Strength in Patients With Idiopathic Pulmonary FibrosisCompletedNCT03588260
- Determinants of Early Cystic Fibrosis Lung DiseaseCompletedNCT03579173
- Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic FibrosisStatus unknownNCT03569904
- Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT03567785
- Continuation of Nintedanib After Single Lung Transplantation in IPF SubjectsTerminatedNCT03562416Phase 2
- Effects of Whole Body Vibration Training in Patients With Interstitial Lung DiseaseStatus unknownNCT03560154Not applicable
- Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF)Status unknownNCT03548181Phase 2
- Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary FibrosisCompletedNCT03542318
- Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic SclerosisStatus unknownNCT03508375Not applicable
- The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female SubjectsCompletedNCT03502902Phase 1
- Muscle Stimulation in Advanced Idiopathic Pulmonary FibrosisCompletedNCT03499275Not applicable
- Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular CharacterizationStatus unknownNCT03486262
- Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary FibrosisTerminatedNCT03480451Not applicable
- Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary RehabilitationTerminatedNCT03477526Not applicable
- Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyCompletedNCT03462524
- Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary FibrosisStatus unknownNCT03440489Not applicable
- Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILDCompletedNCT03438032
- Airway Clearance System (K031876) Phase IV Device EfficacyCompletedNCT03437811
- Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of LifeCompletedNCT03420235Not applicable
- Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary FibrosisCompletedNCT03411876Not applicable
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 2
- Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPFStatus unknownNCT03360032
- Pulmonary Rehabilitation in Idiopathic Pulmonary FibrosisCompletedNCT03326089Not applicable
- Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
- A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic FibrosisTerminatedNCT03309358Phase 1
- Toward Self-management in ILDCompletedNCT03300583
- Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT03274544Not applicable
- Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic FibrosisStatus unknownNCT03273959Not applicable
- Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand TestCompletedNCT03268915Not applicable
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary HypertensionTerminatedNCT03267108Phase 3
- Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary FibrosisWithdrawnNCT03258801
- Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.Status unknownNCT03229343Not applicable
- Structured Exercise Training Programme in Idiopathic Pulmonary FibrosisCompletedNCT03222648Not applicable
- Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT03215147
- Idiopathic Pulmonary Fibrosis Job Exposures StudyCompletedNCT03211507
- MRI Quantification of Pulmonary Fibrosis in Scleroderma PatientsCompletedNCT03207997Not applicable
- Role of Stem Cell Therapy in Interstitial Pulmonary FibrosisStatus unknownNCT03187431Phase 1
- Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CTCompletedNCT03183570Early Phase 1
- Characteristics and Health Related Quality of Life in Idiopathic Pulmonary FibrosisStatus unknownNCT03171870Not applicable
- Quality of Life Study in Participants With IPF Under Pirfenidone TreatmentCompletedNCT03115619
- Diagnostic Value of KL-6 in ILDStatus unknownNCT03103191
- Spanish Version of the KBILD QuestionnaireStatus unknownNCT03103178
- The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female SubjectsCompletedNCT03092102Phase 1